[PubMed] [Google Scholar]Ellington A
[PubMed] [Google Scholar]Ellington A.D., Szostak J.W. Using Apt8-2 would have several potential advantages, raising the possibility of developing new applications
Category: cMET
ns, zero significant
ns, zero significant. dependant on CRISPR technology, fluorescence-activated cell sorter evaluation (FACS), cycloheximide (CHX) pulse-chase, luciferase reporter and chromatin immunoprecipitation